Freestone Grove Partners LP Bristol Myers Squibb CO Transaction History
Freestone Grove Partners LP
- $9.71 Trillion
- Q1 2025
A detailed history of Freestone Grove Partners LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Freestone Grove Partners LP holds 13,816 shares of BMY stock, worth $674,082. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,816
Previous 15,468
10.68%
Holding current value
$674,082
Previous $875 Million
3.68%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,809Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.34 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.74 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.27 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.63 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.24 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...